Evidence map›Paper›PMID 31056712›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2019

Serum dickkopf-related protein 1 and sclerostin may predict the progression of chronic kidney disease in Japanese patients.

Kazu Hamada-Ode, Yoshinori Taniguchi, Yoshiko Shimamura, Shimpei Fujimoto, Yoshio Terada

Abstract readComment
PubMed Publisher
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Secondary Osteoporosis and Metabolic Bone Diseases.Journal of clinical medicine · 2022
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Kazu Hamada-OdeDepartment of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Nankoku, Japan.
Yoshinori TaniguchiDepartment of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Nankoku, Japan.
Yoshiko ShimamuraDepartment of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Nankoku, Japan.
Shimpei FujimotoDepartment of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Nankoku, Japan.
Yoshio TeradaDepartment of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Nankoku, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adaptor Proteins, Signal TransducingBiomarkersBone Morphogenetic ProteinsCase-Control StudiesChronic Kidney Disease-Mineral and Bone DisorderDisease ProgressionGlomerular Filtration RateHumansIntercellular Signaling Peptides and ProteinsJapanKineticsPrognosisRenal Insufficiency, ChronicAdaptor Proteins, Signal TransducingBiomarkersBone Morphogenetic ProteinsDKK1 protein, humanIntercellular Signaling Peptides and ProteinsSOST protein, human

Identifiers

PMID31056712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.